Air Pollution and Inhaled Corticosteroids: Unraveling COPD Lung Vulnerability

Individuals suffering from Chronic Obstructive Pulmonary Disease (COPD) frequently experience worsened symptoms following exposure to polluted air and face a higher risk of hospitalization due to respiratory infections. While inhaled corticosteroids (ICS) are a cornerstone of COPD treatment, their long-term use might paradoxically alter lung immunity, potentially increasing susceptibility to pathogens, especially in polluted environments. This study aims to clarify how inhaled corticosteroids, in conjunction with air pollution, influence lung changes and infection risk in COPD patients.

While this study is not yet recruiting and therefore has no findings, it is designed to uncover critical insights into COPD management. The investigators hypothesize that the combination of ICS and polluted air may lead to specific lung changes that either increase or decrease the likelihood of adverse outcomes. They will meticulously analyze lung function, inflammatory biomarkers, and immune cell profiles to quantify these effects. > The primary objective is to determine if inhaled corticosteroids modify the lung's immune response to air pollution, potentially revealing a significant increase or decrease in vulnerability to infections and exacerbations in COPD patients. This research seeks to provide concrete data on how ICS impacts the lung's resilience in environmentally challenged settings.